With the global demand for smart healthcare rising, particularly in brain tumor diagnosis, traditional MRI image analysis faces significant challenges. According to World Health Organization statistics, approximately 864,000 people worldwide are diagnosed with brain tumors each year, with around 85,000 new cases in the United States in 2021 alone. The need for efficient and accurate diagnostic tools is more pressing than ever. AI-powered solutions are revolutionizing brain tumor diagnosis by utilizing real-time computing capacities to analyze large datasets of complex MRI images, enabling effective analytics and precise management of tumor progression.
To address the complexities of brain tumor diagnosis, Portwell and AItewan have collaborated to develop an AI-driven diagnostic solution. This innovative system leverages Portwell’s MEDS-7081 medical-grade edge AI computing platform, powered by a 13th Gen Intel® Core™ processor and GPU accelerated expansion, to deliver rapid data preprocessing and real-time AI computations. Combined with AItewan’s DeepBT Detector-Plus software, the solution captures multi-scale features from MRI images, precisely segments tumor boundaries, and reduces diagnostic errors. This integration enables early tumor detection, accurate monitoring of tumor progression, and improving treatment success rates.
AItewan’s DeepBT Detector-Plus Software as a Medical Device (SaMD) employs a Dual-pathway Residual U-Net architecture to effectively capture multi-scale features from MRI images, precisely segment tumor boundaries, and reduce subjectivity and human error rates in diagnosis. This innovative algorithm significantly shortens analysis time, enhancing overall medical service efficiency.
Powering this innovation is Portwell’s MEDS-7081, a medical-grade edge AI embedded computing platform designed for rapid data preprocessing and model inference. Built with the high-performance 13th Gen Intel® Core™ processor and supporting NVIDIA GeForce RTX™ GPUs, it offers robust performance for handling large volumes of data in real time. Its medical-grade 900 W power supply ensures stability, while its easy-assembly design and specialized cooling solution guarantee reliability in hospital settings.
The Portwell-AItewan medical AI diagnostic solution integrates seamlessly with existing medical workflows, including DICOM viewers and treatment planning systems (TPS). This advanced brain tumor detection system empowers physicians to accurately assess tumor size, location, and morphological changes, thereby optimizing diagnostic and treatment processes. By providing real-time visualization of tumor changes, the solution enables early intervention and precision treatment, significantly improving patient outcomes.
Combining AItewan’s AI-driven medical diagnostic technology with the high-performance MEDS-7081 edge AI computing hardware, the joint brain tumor detection solution substantially improves diagnostic efficiency and accuracy. Upon this new benchmark, Portwell and AItewan are committed to continuous R&D investment and collaboration to propel an “AI Next” precision healthcare.